Finosh G Thankam

Dr. Finosh G Thankam

Department of Translational Research, Western University of Health Sciences, Pomona, CA-91766, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2021 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Open access
PDF file
BKBrian Kato
Brian Kato
GWGary Wisser
Gary Wisser
DADevendra K. Agrawal
Devendra K. Agrawal
TWTim Wood
Tim Wood
FTFinosh G Thankam
Finosh G Thankam
Demand for donor hearts has increased globally due to cardiovascular diseases. Recently, three-dimensional (3D) bioprinting technology has been aimed at creating clinically viable cardiac constructs for the management of myocardial infarction (MI) and associated complications. Advances in 3D bioprinting show promise in aiding cardiac tissue repair following injury/infarction and offer an alternative to organ transplantation. This article summarizes the basic principles of 3D bioprinting and recent attempts at reconstructing functional adult native cardiac tissue with a focus on current challenges and prospective strategies.

8 January 2021 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
RMRohit Mohindra
Rohit Mohindra
DADevendra K. Agrawal
Devendra K. Agrawal
FTFinosh G Thankam
Finosh G Thankam

1 May 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
RKRebecca Kuan
Rebecca Kuan
DADevendra K. Agrawal
Devendra K. Agrawal
FTFinosh G Thankam
Finosh G Thankam

4 February 2023 in Cell and tissue research
Verified
Journal Article
Open access
PDF file
WFWilliam H. Fang
William H. Fang
Victor BonavidaVictor Bonavida
Victor Bonavida
DADevendra Agrawal
Devendra Agrawal
FTFinosh G Thankam
Finosh G Thankam
Hyperlipidemia impacts millions of people globally and has been the major risk factor for developing atherosclerosis and cardiovascular disease. Interestingly, hyperlipidemic subjects exhibit increased incidence of rotator cuff tendon injury (RCTI) and disorganization of tendon matrix. Low-density lipoproteins (LDL) and its oxidized form (ox-LDL) play a crucial role in hyperlipidemia-driven pro-inflammatory responses in multiple tissues including the tendon. The signaling of oxLDL upregulates the inflammatory cytokines, chemokines, adhesion molecules, and the activation of monocytes/macrophages/resident tendon cells and matrix metalloproteinases impairing the tendon homeostasis resulting in the alteration of extracellular matrix. In addition, the hyperlipidemia-driven immune response and subsequent oxidative stress promote degenerative responses in the tendon tissue. However, the pathological mechanisms underlying the occurrence of RCTI in hyperlipidemia and the effect of ox-LDL in tendon matrix are currently unknown. The present review focuses on the implications and perspectives of LDL/oxLDL on the increased incidence of RCTI.

15 February 2022 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
HCHenry C Chen
Henry C Chen
DADevendra Agrawal
Devendra Agrawal
FTFinosh G Thankam
Finosh G Thankam
Performance of the biomaterials used for regenerative medicine largely depends on biocompatibility; however, the biological mechanisms underlying biocompatibility of a biomaterial within the host system is poorly understood. In addition to the classical immune response against non-self-entities, the sterile inflammatory response could limit the compatibility of biological scaffolds. Whereas the immediate to short-term host response to a biomaterial implant have been characterized, the long-term progression of host–biomaterial relationship has not been described. This article explores the novel concept of biomaterials-driven sterile inflammation (BSI) in long-term biodegradable implants and throws light for possible explanation for the onset of BSI and the associated damage-associated molecular patterns. The understanding of BSI would advance the current strategies to improve biomaterial–host tissue integration and open novel translational avenues in biomaterials-based tissue regeneration. Impact statement: Understanding the novel concept of biomaterials-driven sterile inflammation and associated damage-associated molecular patterns in long-term biodegradable implants would determine their success and improves the tissue engineering and regenerative strategies.

10 June 2022 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
WFWilliam H. Fang
William H. Fang
DADevendra Agrawal
Devendra Agrawal
FTFinosh G Thankam
Finosh G Thankam
Shoulder tendon injuries are the common musculoskeletal disorder resulting in significant pain and disability. These injuries are characterized by chronic inflammation and tissue degeneration. Tendon pathology exhibits poor innate healing ability, enhanced inflammation, disorganized collagen fibers, calcification, and scar tissue formation affecting the normal healing process. Extracellular vesicle, especially exosomes, treatment has been emerging as a potential regenerative strategy improving the outcomes and biomechanical properties, accelerating tenocyte proliferation and migration, reducing inflammation, and facilitating the healing at tendon–bone interface. In this article, we critically reviewed the potential role of exosomes in tendon regeneration and their applications to accelerate the healing response following injury. In addition, the article provides novel insights on the concept of “Smart Exosomes” by programming/manipulating the secretome contents and functions of exosomes in the management of shoulder tendon injury. Impact statement: The exosomes pose tremendous regenerative capacity in otherwise inherently poor tendon healing following shoulder injury. Understanding the exosome biology in the context of tendon injury offers immense opportunities for developing novel regenerative approaches. Herein, we focus on the novel concept of “Smart Exosomes” by programming the regenerative properties of exosomes as a next-generation management strategy for shoulder tendon injury.